EVALUATION OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST-GENERATION JANUS KINASE INHIBITORS

被引:0
|
作者
Kamiya, M. [1 ]
Mori, S. [1 ]
Yamazaki, K. [1 ]
Togawa, D. [1 ]
机构
[1] Kindai Univ, Nara Hosp, Dept Orthopaed & Rheumatol, Ikoma, Japan
关键词
D O I
10.1136/annrheumdis-2022-eular.650
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0670
引用
收藏
页码:608 / 608
页数:1
相关论文
共 50 条
  • [31] DO JANUS KINASE INHIBITORS LEADTO WEIGHT GAIN IN RHEUMATOID ARTHRITIS PATIENTS?
    Venkatachalam, S.
    Mir, N.
    Naina, N.
    Muhammed, H.
    Hirsch, G.
    Sheeran, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [32] Upadacitinib Monotherapy Improves Patient-Reported Outcomes in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate
    Strand, Vibeke
    Buch, Maya
    Tundia, Namita
    Camp, Heidi S.
    Suboticki, Jessica
    Goldschmidt, Debbie
    Wells, Alvin F.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [33] Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapy
    Zeng, Xiaofeng
    Zhao, Dongbao
    Radominski, Sebastiao C.
    Keiserman, Mauro
    Lee, Chang K.
    Meerwein, Sebastian
    Enejosa, Jeffrey
    Sui, Yunxia
    Mohamed, Mohamed-Eslam F.
    Park, Won
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) : 1530 - 1539
  • [34] Selective Janus kinase inhibitors: Promising drugs for rheumatoid arthritis
    Zanwar, Abhishek
    Aggarwal, Amita
    NATIONAL MEDICAL JOURNAL OF INDIA, 2019, 32 (02): : 96 - +
  • [35] UPTAKE OF JANUS KINASE INHIBITORS FOR MANAGEMENT OF RHEUMATOID ARTHRITIS IN AUSTRALIA
    Littlejohn, G.
    Smith, T.
    Tymms, K.
    Youssef, P.
    Cooley, H.
    Ciciriello, S.
    Mathers, D.
    Griffiths, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 325 - 325
  • [36] Uptake of Janus Kinase Inhibitors for Management of Rheumatoid Arthritis in Australia
    Littlejohn, Geoffrey
    Smith, Tegan
    Tymms, Kathleen
    Youssef, Peter
    Cooley, Helen
    Ciciriello, Sabina
    Mathers, David
    OSullivan, Catherine
    Griffiths, Hedley
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [37] PREDICTING INADEQUATE RESPONSE TO JAK INHIBITORS BY CLUSTER ANALYSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Sugawara, M.
    Fujieda, Y.
    Noguchi, A.
    Tanimura, S.
    Shimizu, Y.
    Nakagawa, I.
    Kono, M.
    Kato, M.
    Oku, K.
    Atsumi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 956 - 957
  • [38] A Novel Blood-based Assay That Predicts Clinical Response to TNFa Inhibitors or Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis
    Louie, Maggie
    Fransen, Signe
    Dilger, Katherine
    Lai, Kevin
    Abdueva, Diana
    Chernoff, David
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4561 - 4562
  • [39] Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?
    Martinez-Molina, Cristina
    Feliu, Anna
    Park, Hye S.
    Juanes, Ana
    Diaz-Torne, Cesar
    Vidal, Silvia
    Corominas, Hector
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [40] Changes in the cholesterol profile of patients with rheumatoid arthritis treated with biologics or Janus kinase inhibitors
    Koh, Jung Hee
    Lee, Bong-Woo
    Kim, Wan-Uk
    JOURNAL OF RHEUMATIC DISEASES, 2023, 30 (04): : 234 - 242